Healthleap Raised $38M to Expand AI Screening Platform
Healthcare operators can now leverage AI to identify patient risks faster, potentially reducing costs and improving clinical outcomes.
Updated on Oct. 7, 2026 in Healthcare
Live Poll
Do you believe AI-driven diagnostic tools improve the quality of care in your local hospitals?
Healthleap secured over $38 million to advance its AI software that continuously analyzes electronic health records. The platform flags patients needing immediate clinical attention, aiming to integrate risk data directly into existing hospital workflows.
Why it matters
The technology addresses a critical clinical bottleneck by identifying patient needs days before traditional manual documentation. For operators, this represents a move toward automated, high-accuracy screening that correlates with significant financial and efficiency gains.
The AI model demonstrated an AUROC of 0.95 across full hospital stays and a sensitivity 88% higher than the modified Malnutrition Screening Tool. Evaluated over 166,000 admissions, the platform achieved a 1.1-day reduction in patient length of stay and saved 8,632 bed-days annually.
The players
Healthleap
A developer of AI-driven diagnostic and screening software for hospital health record systems.
Hospital of the University of Pennsylvania
A major academic medical center that documented significant financial impact from the AI screening model.
Cedars-Sinai
A major healthcare institution that recorded increased diagnostic accuracy using the platform.
The details
The platform functions by ingesting both structured data, such as lab results and vital signs, and unstructured clinical notes. By reviewing these records continuously, the system alerts staff to specific health risks earlier than human-led assessments. This integration allows clinical teams to act on patient needs up to four days sooner than when relying on standard dietitian documentation.
Timeline
The evaluation period for the clinical model spanned 3.75 years.
Market Landscape
This development marks a shift from manual, time-bound clinical assessments to continuous, automated data monitoring. It builds on established clinical standards like the modified Malnutrition Screening Tool by providing a higher-sensitivity alternative for managing patient risk.
Operators should monitor the correlation between AI screening tools and patient length-of-stay metrics to assess potential ROI. When evaluating new AI vendors, factor in how seamlessly the system extracts data from existing electronic health records to avoid disrupting established clinical workflows.
The takeaway
The primary insight is that continuous AI monitoring of clinical data can significantly outperform static, periodic screening tools. Operators should review their facility's current documentation lag times as a baseline metric for gauging the potential benefit of implementing similar AI-driven diagnostics.
Further reading
Learn more about the latest innovations in Healthcare affecting hospital operations.
Live Poll
Do you believe AI-driven diagnostic tools improve the quality of care in your local hospitals?
